Atopic Dermatitis Treatment Market By Product (Calcineurin Inhibitors, Corticosteroids, Biologic Therapy, Immunosuppressants, and Others), By Route of Administration (Oral, Topical, Injectable), By End-Users (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Others), and By Region - Trends, Analysis and Forecast till 2034

Due to ongoing research and development efforts, a well-established healthcare infrastructure, and the rising prevalence of eczema, the North American market is anticipated to see a notably high revenue share over the forecast period.

Because of its expanding population, rising incidence of atopic dermatitis, and rising consumer awareness of the need for better treatment, the Asia Pacific market is anticipated to grow at the fastest rate in terms of revenue share during the forecast period.